CuraCell's CDMO partner Zellwerk-Berlin receives GMP licence

CuraCell’s manufacturing partner Zellwerk-Berlin GmbH, a specialized contract development & manufacturing organization (CDMO), receives GMP authorization of its manufacturing site in Brandenburg, Germany. The GMP authorization of Zellwerk-Berlin’s site in Brandenburg is a key milestone for CuraCell in its progress towards filing for the first-in-human clinical trial.